You are using an older browser version. Please use a supported version for the best MSN experience.

Exclusive: EU could pay over $10 billion for Pfizer and CureVac vaccines - source

The European Union could pay more than $10 billion to secure hundreds of millions of doses of the vaccine candidates being developed by Pfizer-BioNTech and CureVac, an EU official involved in the talks has told Reuters. Ciara Lee reports
image beaconimage beaconimage beacon